Allergy medication side effects such as dizziness are more common than many people realise, and can significantly affect daily life. Antihistamines — the most widely used allergy treatments in the UK — work by blocking histamine receptors, but some types also act on the central nervous system, disrupting balance and causing light-headedness or vertigo-like sensations. Decongestants and other allergy medicines can contribute to dizziness through different mechanisms. This article explains why allergy medications cause dizziness, which treatments carry the greatest risk, how to manage symptoms safely, and what alternatives your GP or pharmacist may recommend.

Why Allergy Medications Can Cause Dizziness

Dizziness is one of the more commonly reported side effects associated with allergy medications, particularly antihistamines. Understanding why this happens requires a brief look at how these medicines work. Antihistamines block histamine receptors (primarily H1 receptors) to reduce allergic symptoms such as sneezing, itching, and a runny nose. However, some antihistamines — especially older, first-generation formulations — also cross the blood-brain barrier and act on receptors in the central nervous system (CNS), which can disrupt normal balance and spatial orientation, leading to dizziness or light-headedness.

The vestibular system, which governs balance, relies partly on histamine signalling in the brain. When antihistamines interfere with this pathway, patients may experience a sensation of unsteadiness, spinning (vertigo-like feelings), or general light-headedness. First-generation antihistamines also have significant anticholinergic properties, which further contribute to CNS effects including confusion, impaired coordination, and dizziness — risks that are particularly pronounced in older adults, who may already have balance concerns and are more vulnerable to falls and cognitive effects.

Beyond antihistamines, other allergy treatments can also contribute to dizziness through different mechanisms. Decongestants (e.g., pseudoephedrine, phenylephrine) are sympathomimetic agents that typically raise blood pressure and heart rate; they can cause palpitations, anxiety, and dizziness, and should be avoided in people with uncontrolled hypertension or significant cardiovascular disease. If you are unsure whether a decongestant is suitable for you, seek advice from a pharmacist or GP before use. Oral corticosteroids are occasionally prescribed as short courses for severe allergic exacerbations; dizziness is a recognised but less common adverse effect and these medicines are not first-line treatment for allergic rhinitis.

It is worth noting that some people develop a degree of tolerance to the sedative effects of first-generation antihistamines over time, but this does not occur in everyone. Persistent or troublesome dizziness should always be discussed with a healthcare professional rather than assumed to be self-limiting.

If you experience a suspected side effect from any allergy medicine, you can report it to the MHRA via the Yellow Card scheme at yellowcard.mhra.gov.uk or through the Yellow Card app.

Which Antihistamines and Allergy Treatments Are Most Likely to Cause Dizziness

Not all allergy medications carry the same risk of causing dizziness. The likelihood depends largely on the generation and type of antihistamine, as well as the individual patient's sensitivity.

First-generation (sedating) antihistamines are the most commonly associated with dizziness and CNS-related side effects. These include:

• Chlorphenamine — widely available over the counter in the UK

• Promethazine — also used as a sleep aid and anti-nausea medication

• Hydroxyzine — sometimes prescribed for anxiety or chronic urticaria

Because these medicines readily penetrate the CNS and have anticholinergic activity, they can cause sedation, impaired coordination, and dizziness, particularly at higher doses or in elderly patients. Hydroxyzine carries an additional MHRA safety warning regarding the risk of QT interval prolongation (a cardiac rhythm abnormality). The MHRA advises using the lowest effective dose for the shortest necessary duration, avoiding use in elderly patients where possible, and exercising caution in patients with known cardiac risk factors or those taking other medicines that prolong the QT interval. Patients prescribed hydroxyzine should discuss these risks with their prescriber.

Second-generation (non-sedating) antihistamines are generally considered to have a more favourable tolerability profile, as they are designed to have limited CNS penetration. Common examples include:

• Cetirizine

• Loratadine

• Fexofenadine

However, even second-generation antihistamines can occasionally cause dizziness in some individuals. Cetirizine has a somewhat higher rate of CNS side effects — including sedation and dizziness — compared with loratadine or fexofenadine, as reflected in their respective Summary of Product Characteristics (SmPCs) available via the Electronic Medicines Compendium (EMC). Other low-sedation options, such as bilastine and desloratadine, may be considered if CNS side effects are a concern; a pharmacist or GP can advise on suitability.

Other allergy-related treatments worth noting include intranasal corticosteroids (e.g., fluticasone, mometasone, beclometasone), which are generally well tolerated and rarely cause systemic dizziness when used correctly and at recommended doses. Correct technique is important to minimise any systemic absorption; the NHS provides guidance on how to use steroid nasal sprays properly.

Leukotriene receptor antagonists such as montelukast have been associated with neuropsychiatric effects including mood changes, sleep disturbances, and behavioural changes. The MHRA has issued Drug Safety Updates on these risks. Whilst dizziness is not a primary concern with montelukast, any unusual neurological or psychiatric symptoms should be reported to a GP promptly and the medicine reviewed.

How to Manage Dizziness While Taking Allergy Medication

If you experience dizziness whilst taking allergy medication, there are several practical steps you can take to manage the symptom safely and effectively, without necessarily stopping your treatment abruptly.

Practical self-management strategies include:

• Take sedating antihistamines at night — if your medication is a first-generation antihistamine, taking it in the evening can reduce the impact of dizziness during waking hours. However, be aware that next-day drowsiness and impaired coordination can still occur, particularly in older adults or at higher doses.

• Stay well hydrated — dehydration can worsen dizziness, particularly if you are also taking decongestants.

• Rise slowly from sitting or lying positions — this is especially important if you feel unsteady or light-headed when changing position.

• Avoid alcohol — alcohol significantly amplifies the CNS-depressant effects of sedating antihistamines, worsening dizziness and impairing coordination.

• Avoid driving or operating machinery if you feel drowsy, dizzy, or your alertness is affected — it is illegal in the UK to drive if your ability is impaired by medication. Always check the patient information leaflet (PIL) for your specific medicine. GOV.UK provides guidance on medicines and driving.

• Be cautious with other sedating medicines — combining sedating antihistamines with other CNS depressants such as benzodiazepines, opioids, or certain antidepressants can increase the risk of dizziness and sedation. Seek pharmacist or GP advice if you take any of these medicines.

It is also worth keeping a brief symptom diary, noting when dizziness occurs in relation to when you take your medication, the dose, and any other contributing factors. This information can be very helpful when discussing your symptoms with a GP or pharmacist.

Seek urgent medical help (call 999 or go to A&E) if your dizziness is accompanied by:

• Sudden weakness or numbness in the face, arm, or leg

• Difficulty speaking or understanding speech

• Sudden severe headache unlike any you have had before

• Chest pain, collapse, or loss of consciousness

These may be signs of a serious condition such as stroke or a cardiac event and require immediate emergency assessment.

Contact NHS 111 or seek prompt medical advice if your dizziness:

• Is severe or sudden in onset without an obvious cause

• Is accompanied by palpitations, shortness of breath, or persistent vomiting

• Is associated with hearing loss or tinnitus

• Persists beyond a few days despite adjusting your medication

• Is causing falls or significantly affecting your ability to function

These features may indicate an underlying condition unrelated to your allergy medication, and a thorough clinical assessment would be warranted.

Alternatives and Adjustments Your GP May Recommend

If dizziness is significantly affecting your quality of life, your GP or pharmacist can offer a range of alternatives and adjustments tailored to your individual circumstances. It is important not to simply stop allergy medication without guidance, particularly if it is managing a significant allergic condition such as allergic rhinitis, urticaria, or allergic asthma.

Switching antihistamine type is often the first step. If you are currently taking a first-generation antihistamine, your GP may recommend switching to a second-generation option such as loratadine or fexofenadine, which have a lower propensity for CNS side effects. NICE Clinical Knowledge Summary (CKS) guidance on allergic rhinitis supports the use of non-sedating antihistamines as a first-line option for most patients, precisely because of their improved tolerability profile. Other low-sedation alternatives such as bilastine or desloratadine may also be considered.

Dose adjustment may be considered in some cases, but any changes should remain within the licensed dosing range specified in the PIL and SmPC, and should be made in consultation with a pharmacist or GP. Reducing the dose without professional advice risks inadequate symptom control.

For patients with allergic rhinitis, intranasal corticosteroid sprays (e.g., beclometasone, fluticasone, or mometasone) are recommended by NICE CKS as highly effective first-line treatments. They act locally in the nasal passages with minimal systemic absorption when used correctly, making systemic dizziness an unlikely side effect. Consistent, correct technique is important for both efficacy and safety; the NHS provides guidance on how to use steroid nasal sprays. Topical options such as azelastine nasal spray or sodium cromoglicate eye drops may also be useful for localised symptoms, avoiding systemic effects altogether.

Allergen immunotherapy (desensitisation) may be considered for patients with severe or persistent allergic rhinitis who do not respond adequately to standard pharmacological treatments. NICE technology appraisals have evaluated sublingual immunotherapy tablets for grass pollen and house dust mite allergy. This treatment is initiated and supervised by a specialist, and involves gradually exposing the immune system to the allergen to reduce sensitivity over time.

Finally, your GP may wish to rule out other causes of dizziness — such as benign paroxysmal positional vertigo (BPPV), labyrinthitis, anaemia, or cardiovascular causes — particularly if symptoms persist after changing your allergy medication. A basic clinical review, including lying and standing blood pressure measurement, a full blood count if anaemia is suspected, and a thorough medication review, can help identify contributing factors. A thorough history and examination remain essential to ensure the correct diagnosis and the most appropriate management plan.

Frequently Asked Questions